Guidance for Treating the Older Adults with Colorectal Cancer

Dina Ioffe, Efrat Dotan

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The need for evidence-based data in the rapidly growing group of older patients is vast and more elderly-specific studies are desperately needed, for which there is clear demand from both patients and providers. Notably, many of the studies discussed in this review included unplanned subset analyses based on age and/or were not originally stratified by age; therefore, these data, particularly overall survival data, need to be interpreted with some caution as they may not be statistically valid based on the initial trial design and statistical plan. As we await data from ongoing elderly-specific trials, our recommendation for managing older patients with CRC should include geriatric screening tools (e.g., CSGA, VES-13, G8, CARG, CRASH) to help guide treatment adjustments for improved tolerability without sacrificing efficacy. For patients with a positive screen for significant geriatric concerns, a full geriatric assessment is recommended to guide treatment approach and supportive care. Prior data support the use of all approved medications for CRC in older adults who are fit; however, treatment breaks and dose attenuation with potential escalation are reasonable options for these patients. Ultimately, management decisions in the care of older adults with mCRC must be made through shared decision-making with the patient with consideration for the patient’s functional status, comorbidities, goals of care, social support, as well as potential toxicities and possible effect on QoL.

Original languageEnglish
Pages (from-to)644-666
Number of pages23
JournalCurrent Treatment Options in Oncology
Volume24
Issue number6
DOIs
StatePublished - Jun 2023

Keywords

  • Colon cancer
  • Elderly
  • Geriatric assessment
  • Older patient
  • Rectal cancer

Fingerprint

Dive into the research topics of 'Guidance for Treating the Older Adults with Colorectal Cancer'. Together they form a unique fingerprint.

Cite this